References
- Stone T, Perkins M. Quinolinic acid: a potent endogenous excitant at amino acid CNS receptors. Eur J Pharmacol 1981; 72: 411–412.
- Perkins M, Stone T. An iontophoretic investigation of the actions of convulsant kynurenines and their interactions with the endogenous excitant quinolinic acid. Brain Res 1982; 247: 184–187.
- Schwarcz R, Whetsell W Jr, Mangano R. Quinolinic acid: an endogenous metabolite that causes axon-sparing lesions in rat brain. Science 1983; 219: 316–319.
- Schwarcz R, Brush G, Foster A et al. Seizure activity and lesions following intrahippocampal injections of quinolinic acid. Exp Neurol 1984; 84: 1–10.
- Schwarcz R, Speciale C, Okuno E et al. Quinolinic acid: a pathogen in seizure disorders? Adv Exp Med Biol 1986; 203: 697–707.
- Heyes M P, Brew B, Martin A. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991; 29: 202–209.
- Schwarcz R, Okuno E, White R, et al. 3-hydroxyanthranilate oxidase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci USA 1988; 85: 4079–4081.
- Whetsels V Jr. The use of organotypic tissue culture for study of amino acid neurotoxicity and its antagonism in mammalian central nervous system. Clin Neuropharmacol 1984; 7: 248–250.
- Feldblum S. Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia 1988; 29: 523–529.
- Moroni F, Russi P, Lombardi G et al. Presence of kynurenic acid in the mammalian brain. J Neurochem 1988; 51: 177–180.
- Moroni D, Lombardi G, Moneti G et al. The excitotoxin quinolinic acid is present in the brain of several animal species and its cortical content increases during the aging process. Neurosci Lett 1984; 47: 51–55.
- Jahr C, Jessel T. Synaptic transmission between dorsal root ganglion and dorsal horn neurons in culture: antagonism of monosynaptic excitatory postsynaptic potentials and glutamate excitation by kynurenate. J Neurosci 1985; 5: 2281–2289.
- Kohler C, Eriksson E, Okuno E et al. Localization of quinolinic acid metabolizing enzymes in rat brain. Immunohistochemical studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinate phosphoribosyl transferase. Neurosci 1988; 27: 49–76.
- Moffett J, Espey M, Gaudet S et al. Antibodies to quinolinic acid reveal localization in select immune cells rather than neurons or astroglia. Brain Res 1993; 623: 337–340.
- Foster A, Whetsel W, Bird E et al. Quinolinate phosphoribosyltransferase in human and rat brain: activity in Huntington disease and quinolinate-lesioned rat striatum. Brain Res 1985; 336: 207–14.
- Okuno E, Kohler C, Schwarcz, R. Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain. J Neurochem 1987; 49: 771–780.
- Okuno E, Schwarcz R. Purification of quinolinate phosphoribosyltransferase from rat liver and brain. Biochem Biophys Acta 1985; 841: 112–119.
- Mitchell R A, Kang H H, Henderson L M. Inactivation during functioning of 3-hydroxyanthranilate oxidase resulting from oxidation of bound ferrous iron. J Biol Chem 1962; 238: 1151–1155.
- Ogasawara N, Gander J E, Henderson L M. Purification and properties of 3-hydroxyanthranilate oxidase from beef kidney. J Biol Chem 1966; 241: 613–619.
- Chance B. The intracellular oxidation-reduction state at high and low oxygen concentrations. In: Lambertsen C J (ed) Underwater Physiology. Academic Press 1971: 19–22.